A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities.

EMBO Mol Med · 2025 · PMC12162887 · PMID 40295888

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a similar trend was observed also for both IR-GBM67 and IR-GBM39, the comparison with the untreated XGBM67/XGBM39 did not reach statistical significance (Figs. 2E and EV2E , respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.